Literature DB >> 16505494

Stability of body weight in type 2 diabetes.

Zoobia W Chaudhry1, Mary C Gannon, Frank Q Nuttall.   

Abstract

OBJECTIVE: There is a concern that an "epidemic of obesity" is occurring in Western societies. One consequence of obesity is that type 2 diabetes may develop. Presumably, a great increase in body weight would continue in people with diabetes and may be accelerated due to pharmacological treatment. In this retrospective study, we tested the hypothesis that the weight gain in a diabetic population is greater than that in the general population. RESEARCH DESIGN AND METHODS: Data were obtained from the records of 205 adult men who have attended a diabetes clinic for > or =5 years. Their weight and glycohemoglobin at the last visit were compared with the initial visit data. The subjects were categorized according to treatment modalities. The mean follow-up was 9.4 years (range 5-23).
RESULTS: For the group as a whole, the mean increase in body weight was 0.23 +/- 0.2 kg/year. BMI or initial age had little effect on the rate of weight gain. Treatment regimen used did have an effect on weight change. In subjects treated with insulin, with or without oral agents, body weight increased at a rate of 0.44 +/- 0.1 kg/year. In subjects treated with metformin or metformin and a sulfonylurea, there was a mean loss in weight, i.e., -0.24 +/- 0.09 kg/year, and with sulfonylureas alone weight increased by 0.42 +/- 0.2 kg/year.
CONCLUSIONS: The men treated with insulin alone or insulin combined with oral agents gained weight at a rate comparable with that reported for the general population, i.e., the weight gain was not extraordinary. Metformin treatment resulted in a modest loss of weight.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16505494     DOI: 10.2337/diacare.29.03.06.dc05-1703

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  13 in total

1.  BMI change patterns and disability development of middle-aged adults with diabetes: a dual trajectory modeling approach.

Authors:  Ching-Ju Chiu; Linda A Wray; Feng-Hwa Lu; Elizabeth A Beverly
Journal:  J Gen Intern Med       Date:  2013-03-06       Impact factor: 5.128

2.  Weight change and glycemic control after diagnosis of type 2 diabetes.

Authors:  Adrianne C Feldstein; Gregory A Nichols; David H Smith; A Gabriela Rosales; Nancy Perrin
Journal:  J Gen Intern Med       Date:  2008-06-28       Impact factor: 5.128

3.  Insulin use and weight maintenance in well-controlled type 2 diabetes: a prospective cohort study.

Authors:  Mary Margaret Huizinga; Kevin D Niswender; Tebeb Gebretsadik; Russell L Rothman; Ayumi K Shintani; Tom A Elasy
Journal:  Obesity (Silver Spring)       Date:  2008-06-12       Impact factor: 5.002

4.  Management of diabetes across the course of disease: minimizing obesity-associated complications.

Authors:  Caroline M Apovian
Journal:  Diabetes Metab Syndr Obes       Date:  2011-10-12       Impact factor: 3.168

5.  Weight changes following the diagnosis of type 2 diabetes: the impact of recent and past weight history before diagnosis. results from the Danish Diabetes Care in General Practice (DCGP) study.

Authors:  Niels de Fine Olivarius; Volkert Dirk Siersma; Rasmus Køster-Rasmussen; Berit Lilienthal Heitmann; Frans Boch Waldorff
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

6.  Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study).

Authors:  C McAdam-Marx; B K Bellows; S Unni; J Mukherjee; G Wygant; U Iloeje; J N Liberman; X Ye; F J Bloom; D I Brixner
Journal:  Int J Clin Pract       Date:  2014-08-12       Impact factor: 2.503

7.  The determinants of complication trajectories in American Indians with type 2 diabetes.

Authors:  Evan L Reynolds; Gulcin Akinci; Mousumi Banerjee; Helen C Looker; Adam Patterson; Robert G Nelson; Eva L Feldman; Brian C Callaghan
Journal:  JCI Insight       Date:  2021-05-24

8.  Weight change in diabetes and glycemic and blood pressure control.

Authors:  Adrianne C Feldstein; Gregory A Nichols; David H Smith; Victor J Stevens; Keith Bachman; A Gabriela Rosales; Nancy Perrin
Journal:  Diabetes Care       Date:  2008-06-20       Impact factor: 17.152

9.  Cost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in sweden.

Authors:  Aliasghar A Kiadaliri; Ulf G Gerdtham; Bjorn Eliasson; Katarina Steen Carlsson
Journal:  Diabetes Ther       Date:  2014-09-12       Impact factor: 2.945

10.  Body Mass Index: Obesity, BMI, and Health: A Critical Review.

Authors:  Frank Q Nuttall
Journal:  Nutr Today       Date:  2015-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.